9th Circ. Revives Claims That Medtronic Skirted FDA Review
The Ninth Circuit on Friday revived allegations from a whistleblower's suit that Medtronic fraudulently obtained U.S. Food and Drug Administration clearance for certain spinal surgery implants, but affirmed the dismissal of other...To view the full article, register now.
Already a subscriber? Click here to view full article